David J. Katzoff - 14 Jun 2021 Form 3 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Chief Operating Officer
Signature
/s/ David J. Katzoff
Issuer symbol
ALZN
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
3
Filing time
14 Jun 2021, 19:55:49 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALZN Common Stock 18,000 14 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALZN Warrants 14 Jun 2021 Common Stock 9,000 $3.00 Direct
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 400,000 $1.00 Direct F1
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 850,000 $1.50 Direct F2
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 250,000 $1.50 Direct F3
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 1,000,000 $1.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests ratably over forty-eight (48) months commencing after January 20, 2019.
F2 Vests quarterly over sixteen (16) quarters commencing after October 31, 2019.
F3 Vests quarterly over sixteen (16) quarter commencing after November 25, 2019.
F4 Vests based upon certain performance criteria. Of these options, none shares of Common Stock are vested and exercisable.